5 days ago
ONC
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 9%
#484 out of 5532 analysts
Average Return
+9.57%
Win Rate
58%103 out of 177
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-20 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-26 - 2020-06-10 | Strong Buy |
Insmed IncINSM | +171.72% | $73.15 | $198.76 | 2024-11-22 - 2025-11-21 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +141.47% | $35.18 | $84.95 | 2025-09-24 - 2026-09-01 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
25 days ago
VRTX
2 months ago
JAZZ
2 months ago
IONS
2 months ago
ONC
3 months ago
AKTS
a year ago
ONC
a year ago
IONS
a year ago
MIRM
a year ago
LEGN
a year ago
INSM
a year ago
ASND
a year ago
ALNY
a year ago
ONC
a year ago
ALNY
a year ago
INSM
a year ago
ALNY
a year ago
ASND
2 years ago
ALNY
2 years ago
ASND
2 years ago
INSM
2 years ago
ASND
2 years ago
INSM
2 years ago
ITCI
2 years ago
ONC
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Beone Medicines LtdONC | 10 | Strong Buy | $445.00 | +23.05% | Maintains | 5 days ago |
Alnylam Pharmaceuticals IncALNY | 12 | Strong Buy | $369.00 | +67.81% | Maintains | 6 days ago |
Biocryst Pharmaceuticals IncBCRX | 5 | Hold | $13.00 | +60.49% | Maintains | 6 days ago |
Incyte CorpINCY | 11 | Hold | $123.00 | +7.77% | Maintains | 8 days ago |
Ionis Pharmaceuticals IncIONS | 9 | Strong Buy | $70.00 | +60.92% | Maintains | 14 days ago |
Vertex Pharmaceuticals IncVRTX | 11 | Strong Buy | $560.00 | +11.22% | Reinstates | 25 days ago |
Emergent Biosolutions IncEBS | 3 | Strong Sell | N/A | N/A | Reinstates | a month ago |
Amarin Corp PLCAMRN | 6 | Strong Sell | $13.00 | +7.53% | Reinstates | a month ago |
Immunocore Holdings PLCIMCR | 6 | Strong Buy | $50.00 | +68.98% | Reinstates | a month ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $40.00 | +57.98% | Reinstates | a month ago |
Nektar TherapeuticsNKTR | 7 | Hold | $65.00 | +53.96% | Reinstates | a month ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $88.00 | +50.32% | Reinstates | a month ago |
Moderna IncMRNA | 15 | Strong Sell | $77.00 | -62.11% | Maintains | a month ago |
Insmed IncINSM | 11 | Strong Buy | $175.00 | +68.54% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Strong Buy | $276.00 | +16.93% | Maintains | 2 months ago |
Alkermes PLCALKS | 9 | Hold | $61.00 | +42.66% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 10 | Strong Buy | $687.00 | +28.08% | Maintains | 2 months ago |
Aktis Oncology IncAKTS | 2 | Strong Buy | $33.00 | +78.19% | Maintains | 3 months ago |
Novocure LtdNVCR | 6 | Hold | $17.00 | +11.84% | Reinstates | 3 months ago |
Denali Therapeutics IncDNLI | 7 | Strong Buy | $29.00 | +45.66% | Reinstates | 3 months ago |
Legend Biotech CorpLEGN | 5 | Hold | $35.00 | +86.42% | Reinstates | 3 months ago |
Mirum Pharmaceuticals IncMIRM | 5 | Strong Buy | $125.00 | +53.51% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 9 | Hold | $65.00 | -39.99% | Maintains | a year ago |
Biontech SeBNTX | 14 | Hold | $120.00 | +22.90% | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $119.00 | +106.81% | Maintains | a year ago |
Ascendis Pharma AASND | 15 | Strong Buy | $264.00 | +15.77% | Maintains | a year ago |
Crinetics Pharmaceuticals IncCRNX | 4 | Strong Buy | $52.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | N/A | Maintains | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | N/A | Downgrades | 3 years ago |
Esperion Therapeutics IncESPR | 6 | Hold | N/A | N/A | Reinstates | 3 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 4 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $240.00 | N/A | Upgrades | 5 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 5 years ago |
Aprea Therapeutics IncAPRE | 2 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 5 years ago |
Axcella Health IncAXLA | 3 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 5 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Lexicon Pharmaceuticals IncLXRX | 2 | Hold | $7.00 | N/A | Upgrades | 6 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 7 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 7 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Novavax IncNVAX | 3 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 8 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 8 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 9 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Advanced Accelerator Applications SaAAAP1 | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.